Happiness Biotech up 53% premarket on coronavirus-stoked surge in business 
 Chinese nutraceutical and dietary supplement maker Happiness Biotech Group (NASDAQ:HAPP) jumps   premarket on increased volume in reaction to its announcement that sales of its Cordyceps mycelia products surged over 100% (~$1.2M) this month due the the coronavirus outbreak.

The company says its Cordyceps Mycelia Oral Liquid, approved in China in 1997, improves body resistance and prevents disease.